Does detection of severe coronary artery calcifications with low-dose thoracic computed tomography predict adverse cardiovascular events and survival in liver transplant recipients who smoke?
Low-dose thoracic CT can simultaneously screen for lung cancer and stratify cardiovascular risk by detecting severe coronary artery calcifications in liver transplant recipients who smoke.
LDCT enables the detection of severe CAC in LTRs, which is associated with an increased risk of ACEs and reduced survival, thus supporting the use of LDCT both for lung cancer screening and for cardiovascular risk stratification in LTRs who smoke with a low radiation exposure and without the need of contrast medium.
Lam et al. (Thu,) studied this question.